Home Financial Markets Why Brooklyn ImmunoTherapeutics Inc. (BTX) stock rallied on Tuesday, April 19, 2021?

Why Brooklyn ImmunoTherapeutics Inc. (BTX) stock rallied on Tuesday, April 19, 2021?

Brooklyn ImmunoTherapeutics Inc. (BTX) shares gained 6.23% in the after-market session on Tuesday, April 19, 2021. Earlier BTX stock soared 27.31% in a normal trading session.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

BTX shares have surged 325.65% over the last 12 months, and they have moved up by 64.81% in the past week. Over the past three months, the stock has gained 91.96%, while over the past six months, it has added 127.67%.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Let’s try to find out the reason behind its Tuesday surging.

Read More

Inducement Grants

On April 19, 2021, Brooklyn ImmunoTherapeutics reported that the company granted a nonqualified stock option covering 2,627,915 shares of Brooklyn’s common stock to Dr. Federof.

Previously on 16 April 2021, Dr. Federoff was granted a nonqualified stock option covering 597,253 shares of Brooklyn’s common stock. This inducement grant is given to Dr. Federoff for his devoted continuous service with Brooklyn.

mRNA Technology Platform license Acquisition

On April 15, 2021, Brooklyn ImmunoTherapeutics paid$1 million to acquire the Factor Bioscience’s and Novellus’ mRNA Gene Editing and Cell Therapies technology license which has been extended till May 21, 2021.

Upon completion, Brooklyn would be able to start a patented process to seek to develop gene-edited compounds using mRNA which are used for the treatment of several solid tumour and liquid indications, sickle cell anemia, as well as for several additional inherited disorders.

New Board member

On April 15, 2021, Brooklyn ImmunoTherapeutics appointed Dennis H. Langer, M.D., J.D. to the Company’s Board as an Independent Director, effective May 1, 2021.

New CEO appointment

On April 6, 2021, Brooklyn ImmunoTherapeutics appointed Howard J. Federoff, M.D., Ph.D., as Chief Executive Officer and President and a director as of 16 April 2021.

Ronald Guido was replaced by Dr. Federoff, who was serving as Interim CEO and will remain on Brooklyn’s management team as Chief Development Officer.

Reverse merger completion with NTN Buzztime

On March 25, 2021, Brooklyn ImmunoTherapeutics, announced the completion of the reverse merger with NTN Buzztime, Inc. Brooklyn’s common stock has start trading on the NYSE American Exchange under the ticker symbol “BTX” from March 26, 2021.

According to the agreement, Brooklyn ImmunoTherapeutics has merged with NTN Buzztime and became a wholly-owned subsidiary of NTN Buzztime. NTN Buzztime has changed its name to Brooklyn ImmunoTherapeutics.

Let’s have a look at the recent available financial figures of NTN Buzztime. NTN Buzztimeannounced its financial results on November 13, 2020, for the third quarter ended September 30, 2020.

3Q 2020 financial highlights

  • For the third quarter 2020, total revenues were $1.5 million, up to $0.7 million (or 96%) sequentially as compared to the second quarter of 2020, but down from $4.6 million in the third quarter of 2019
  • operating expenses for the reported quarter were $2.9 million compared with $4.9 million in the third quarter of 2019.
  • NTN Buzztime suffered a net loss of 1.5 million, or $0.50 per share to common shareholders in Q3 2020 compared with $351,000, or $0.12 per share, in the prior-year third quarter.
  • As of September 30, 2020, NTN Buzztime had cash, cash equivalents, and unrestricted cash of $1.7 million.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

BTX has performed exceptionally well in the last 12 months and there is no recent development behind its positive momentum on Tuesday. We can expect a stable performance for the rest of the week.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

My Size Inc. (NASDAQ: MYSZ) stock plunged during after-hour trading, given no latest update

My Size Inc. (NASDAQ: MYSZ) stock surged by 24.87% at last close whereas the MYSZ stock price declined by 4.13% in the after hours...

Etsy, Inc. (ETSY) Stock Continues to Trend Down After a Stellar 2020 Set Expectations Too High

Etsy, Inc. (ETSY) stock prices were down by a marginal 2.06% as of the market closing on May 5th, 2021, bringing the price per...

Cryoport Inc. (NASDAQ:CYRX) stock surged in the current trading session; here’s why

At last check, in the current trading session, CYRX stock surged by 11.28% to the price of $61.45. CYRX stock closed the previous session...

Amryt (AMYT) Stock Is Declining Before Market Open, I Wonder Why?

The price of Amryt Pharma plc (NASDAQ:AMYT) shares were down -8.88% to $11.7 at last check in premarket trading. AMRYT stock closed at $12.84...

Why DavidsTea Inc (DEA) stock surged in the after-market session on Tuesday after an early loss?

DavidsTea Inc (DEA) stock started the Tuesday, May 4 with negativity and lost 7.74% in the normal trading to close at $3.22 per share....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.